RNN798

N/A

Report date: 2025/11/04 10:59:14
NME

Base Information

Drug NameRNN798
Drug Alias NameRNN798RNN-798
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Small Interfering RNA
Mechanisms of ActionLipid transferase CIDEB modulators
TargetsLipid transferase CIDEB
Therapy Area/IndicationsHyperlipidemiasMetabolic Dysfunction-Associated Steatotic Liver Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesRona Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesRona Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsHyperlipidemiasMetabolic Dysfunction-Associated Steatotic Liver Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A